ClinicalTrials.gov
ClinicalTrials.gov Menu

Sayana-Uniject Volumetric Delivery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01298479
Recruitment Status : Completed
First Posted : February 17, 2011
Last Update Posted : February 17, 2011
Sponsor:
Information provided by:
Pfizer

Brief Summary:
The purpose of this study is to determine the volumetric delivery of the Uniject.

Condition or disease Intervention/treatment
Volume Delivery. Other: Uniject

Detailed Description:
Observe subjects deliver the drug None used

Study Type : Observational
Estimated Enrollment : 25 participants
Time Perspective: Prospective
Official Title: Quantitative Determination of the Volume of Suspension Delivered Via the Uniject Delivery System Following Simulated Subcutaneous Injection by Healthcare Professionals Into a Synthetic Subcutaneous Injection Training Device
Study Start Date : May 2010
Actual Primary Completion Date : June 2010
Actual Study Completion Date : June 2010

Group/Cohort Intervention/treatment
Group 1
All subjects
Other: Uniject
single use container




Primary Outcome Measures :
  1. Weight of drug suspension delivered (estimated by change in mass of the Uniject(TM) delivery system). [ Time Frame: Visit 1 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
nurses
Criteria

Inclusion Criteria:

  • Nurses

Exclusion Criteria:

  • Non-nurses

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01298479


Locations
Belgium
Pfizer Investigational Site
Bruxelles, Belgium, B-1070
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer

Additional Information:
Responsible Party: Director, Clinical Trial Disclosure Group, Pfizer, Inc.
ClinicalTrials.gov Identifier: NCT01298479     History of Changes
Other Study ID Numbers: A6791034
First Posted: February 17, 2011    Key Record Dates
Last Update Posted: February 17, 2011
Last Verified: February 2011

Keywords provided by Pfizer:
volume delivery